I have worked as Senior Scientist, New Technology Evaluation at Hoffman-LaRoche, a Swiss multinational healthcare company and later went on to work as Senior Principal Systems Engineer at Elbit Systems of America. I am a member of the founding team of Symbollon Pharmaceuticals, Iotech International and I2Pure, all three of which are focused on the development and commercialization of proprietary drugs based on molecular iodine technology.I have led formulation teams responsible for the development of several iodine-based products including the Violet tablet, ioRinse line of oral care products and the initial generation (powder) of the Iodozyme teat dip product marketed by DeLaval. I have also published basic and applied research on iodine formulations and the biochemistry of iodine/thyroid hormones.My list of inventions includes a molecular iodine-based solid oral dosage for mammary dysplasia and methods, systems, and devices to identify microorganisms in culture samples. I have dedicated more than 25 years to the development of applicative areas of iodine-based formulations, bio-analytical assays, and in vitro diagnostic (IVD) medical devices.I have 25+ patents in the iodine field. My patent listings include applications pending approval as well as patents already granted by the USPTO. https://patents.justia.com/inventor/jack-kessler